Clinical Director, Lysosomal Storage Diseases Program Massachusetts General Hospital & Instructor of Medicine Harvard Medical School, USA

Amel Karaa, MD is a Board-certified internist and medical geneticist, who dedicated her professional life to treating patients with complex medical conditions by providing excellent clinical care, and therapeutics opportunities for those with mitochondrial and lysosomal storage disorders. She has established a specialized program evaluating hundreds of national and international patients.   Dr Karaa is the 2013 United mitochondrial disease foundation (UMDF) fellow, a site investigator for the NIH North American Mitochondrial Disease Consortium (NAMDC), on the scientific/medical board of the UMDF, the medical board of the national advocacy group MitoAction, multiple medical boards for different lysosomal storage disorders and as of June 2018, the elected president of the Mitochondrial Medicine Society (MMS).